Building access to the Regenstrief Institute is restricted at least through September 13, 2020. More on our coronavirus precautions.
See our coronavirus precautions.

Findings from a study conducted by Regenstrief Institute and Indiana University School of Medicine research scientists were cited by the U.S. Preventive Services Task Force in its announcement that it can neither recommend nor oppose cognitive screening for older adults in primary care.

The study, led by Nicole Fowler, PhD, MHSA, evaluated the pros and cons of screening older adults during primary care appointments. Results showed there were no differences in health-related quality of life, depression or anxiety, advance care planning, hospitalizations or emergency department visits between people who were screened and people who were not.

The CHOICE study is the first randomized controlled trial to assess both the potential harms and benefits of conducting cognitive screenings of older adults in primary care. The leaders of the study say the findings are important because they scientifically negate the concern that dementia screenings may be harmful to patients.

Members of the U.S. Preventive Services Task Force determined that this study and others currently do not offer conclusive evidence of benefits to screening for cognitive impairment, so it cannot make a recommendation for or against the screening. The task force’s work informs policies set by Medicare and private insurers.

Read the recommendation

Read some of the media coverage

Related Influence

Jul 08, 2020 • Influence
Regenstrief research scientists part of leadership for American Delirium Society Digital Meeting
Dr. Noll Campbell, Dr. Babar Khan, and Dr. Sikandar Khan man "mission control" during the meeting. The COVID-19 pandemic has posed many challenges for conference organizers around the world. Two Regenstrief Institute research scientists successfully adjusted the American Delirium Society (ADS) conference from in-person to virtual and attracted more than 400 registrations from around the…
Continue Reading >
Jul 06, 2020 • Influence
Pandemic spotlights nursing home needs; Regenstrief scientist leading company to address the gaps
Probari, Inc., a company dedicated to improving nursing home care and led by Regenstrief research scientist and Indiana University School of Medicine associate professor Kathleen Unroe, M.D., MHA, was highlighted in Inside Indiana Business. The COVID-19 pandemic has exposed many areas of weakness within the nursing home system, areas that Probari is working to address.…
Continue Reading >